Bayer (BAYN.F) stock price, revenue, and financials

Bayer market cap is €53.1 b, and annual revenue was €43.55 b in FY 2019

€53.1 B

BAYN.F Mkt cap, 23-Sept-2020

€43.5 B

Bayer Revenue FY, 2019
Bayer Revenue growth (FY, 2018 - FY, 2019), %10%
Bayer Gross profit (FY, 2019)26.1 B
Bayer Gross profit margin (FY, 2019), %59.9%
Bayer Net income (FY, 2019)2.4 B
Bayer EBIT (FY, 2019)4.2 B
Bayer Cash, 31-Dec-20193.2 B
Bayer EV89.1 B

Bayer Revenue

Bayer revenue was €43.55 b in FY, 2019 which is a 10% year over year increase from the previous period.

Embed Graph

Bayer Revenue Breakdown

Embed Graph

Bayer revenue breakdown by business segment: 12.5% from Consumer Health, 41.2% from Pharmaceuticals, 45.5% from CropScience and 0.7% from Other

Bayer revenue breakdown by geographic segment: 15.3% from Latin America, 19.8% from Asia / Pacific, 34.6% from North America and 30.3% from Europe / Middle East / Africa

Bayer Income Statement

Annual

EURFY, 2016FY, 2017FY, 2018FY, 2019

Revenue

46.8b35.0b39.6b43.5b

Revenue growth, %

1%(25%)13%10%

Cost of goods sold

20.3b11.4b17.0b17.5b

Gross profit

26.5b23.6b22.6b26.1b

Gross profit Margin, %

57%67%57%60%

Sales and marketing expense

12.5b11.1b12.8b12.3b

R&D expense

4.7b4.5b5.2b5.3b

General and administrative expense

2.3b2.0b2.7b3.9b

Operating expense total

20.3b18.6b23.7b23.5b

EBIT

7.0b5.9b3.9b4.2b

EBIT margin, %

15%17%10%10%

Interest expense

691.0m691.0m1.4b1.6b

Interest income

139.0m272.0m321.0m294.0m

Pre tax profit

5.9b4.6b2.3b2.9b

Income tax expense

1.3b1.3b607.0m450.0m

Net Income

4.5b7.3b1.7b2.4b

EPS

5.48.41.82.5

Bayer Balance Sheet

Annual

EURFY, 2016FY, 2017FY, 2018FY, 2019

Cash

1.9b7.6b4.1b3.2b

Accounts Receivable

11.0b8.6b11.8b11.7b

Inventories

8.4b6.6b11.0b10.8b

Current Assets

30.4b30.1b30.9b32.6b

PP&E

13.1b7.6b12.9b12.5b

Goodwill

16.3b14.8b38.1b39.1b

Total Assets

82.2b75.1b126.3b126.3b

Accounts Payable

6.4b5.1b5.4b6.4b

Short-term debt

3.4b1.9b3.7b2.2b

Current Liabilities

18.5b13.6b22.8b23.2b

Long-term debt

16.2b12.5b37.7b36.9b

Non-Current Liabilities

31.8b24.6b57.3b55.5b

Total Debt

19.6b14.4b41.4b39.1b

Common Stock

2.1b2.1b2.4b2.5b

Total Equity

31.9b36.9b46.1b47.5b

Debt to Equity Ratio

0.6 x0.4 x0.9 x0.8 x

Debt to Assets Ratio

0.2 x0.2 x0.3 x0.3 x

Financial Leverage

2.6 x2 x2.7 x2.7 x

Bayer Cash Flow

Annual

EURFY, 2016FY, 2017FY, 2018FY, 2019

Net Income

4.5b7.3b1.7b2.4b

Depreciation and Amortization

3.7b2.7b6.4b5.4b

Accounts Receivable

(552.0m)(18.0m)2.5b14.0m

Inventories

(3.0m)(293.0m)615.0m(103.0m)

Accounts Payable

452.0m265.0m(44.0m)759.0m

Cash From Operating Activities

9.1b8.1b7.9b8.2b

Purchases of PP&E

(2.6b)(2.4b)(2.6b)(2.6b)

Cash From Investing Activities

(8.7b)(432.0m)(34.2b)(671.0m)

Long-term Borrowings

(15.9b)(12.8b)(47.3b)(11.8b)

Dividends Paid

(2.1b)(2.4b)(2.4b)(2.6b)

Cash From Financing Activities

(350.0m)(1.9b)23.4b(8.4b)

Net Change in Cash

10.0m5.8b(2.8b)(853.0m)

Interest Paid

853.0m801.0m1.3b1.5b

Income Taxes Paid

2.1b1.8b2.1b2.6b

Bayer Ratios

EURQ1, 2016

EV/EBIT

48.4 x

EV/CFO

85.4 x

Debt/Equity

0.8 x

Debt/Assets

0.3 x

Financial Leverage

3.1 x

Bayer Operating Metrics

FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019Jan, 2020

Countries

147 151 152 148 153

Suppliers

112 k112.50 k110.90 k93.33 k101.19 k86.40 k

Patent Applications

68.20 k66.70 k50.80 k48.10 k

Patents Issued

8.30 k7.20 k5 k4.70 k

Engineers And Scientists

15 k

Projects Supported

53 50

Phase II Trials Products

12

Phase III Trials Products

14 17 17 9

Approved Phase Products

2

Bayer Sustainability Metrics

 FY, 2019

Water Used

59 m cubic meters

Total Recordable Incident Rate

0.46

Total Greenhouse Gas Emissions

3.71 m metric tons of carbon dioxide equivalent

Hazardous Waste Generated

303 k metric tons

Greenhouse Gas Emissions (Scope 2, Market-Based)

3.71 m metric tons of carbon dioxide equivalent

Greenhouse Gas Emissions (Scope 1)

2.03 m metric tons of carbon dioxide equivalent

Energy Use Intensity

247 kWh per 1000 EUR

Energy Consumption

38.74 k TJ

Bayer Human Capital

Bayer's employees are reported to be approximately 40% female and 60% male.
FY, 2019FY, 2018FY, 2017FY, 2016FY, 2015
Production39.3 %40.6 %39.7 %43.6 %40.9 %
Sales and Marketing36.3 %36.1 %36.7 %34.9 %38.3 %
Research and Development15.4 %14.8 %14.1 %13.2 %12.6 %
General and Administrative 9 %8.5 %9.5 %8.3 %8.2 %
FY, 2019FY, 2018FY, 2017FY, 2016FY, 2015
Male59.5 %60.8 %59.8 %62.6 %62.6 %
Female40.5 %39.2 %40.2 %37.4 %37.4 %